HOME >> BIOLOGY >> NEWS
Influenza infection attracts pneumonia bacteria

SALT LAKE CITY May 22, 2002 -- Lung cells infected with the influenza A virus are more likely to bind with bacteria that cause pneumonia than uninfected cells, but this phenomenon can be reversed with antiviral treatment. Researchers from the University of Kansas Medical Center present their findings today at the 102nd General Meeting of the American Society for Microbiology. Bacterial pneumonia caused by Streptococcus pneumoniae can occur secondary to viral infections such as influenza. Previous studies have shown that by treating the influenza virus with Tamiflu, a neuraminidase inhibitor that attacks the influenza virus at the cellular level, secondary complications such as pneumonia can be reduced, says Dr. Rebecca Horvat, one of the researchers on the study.

Dr. Horvat and her colleagues examined the relationship between the binding of S. pneumoniae bacteria to a lung epithelial cell line (the cells that line the respiratory system) with and without influenza A infection. Preliminary studies showed that after 24, 48 or 72 hours of viral infection, the bacteria bound to the influenza-infected cells 4 to 10 times higher than uninfected cells. When the flu virus was treated with Tamiflu, the increased binding was reversed.

An influenza-infected lung epithelial cell will bind more S. pneumoniae bacteria than uninfected cells. Treatment with Tamiflu at doses used to treat influenza infections can prevent this increased bacterial binding, and perhaps prevent post-influenza complications, such as pneumonia, says Dr. Horvat.

S. pneumoniae continues to be the leading cause of community-acquired pneumonia worldwide. Although the ability of bacteria to bind to host cells is the first step in the process of infection, few studies have correlated S. pneumoniae cell binding with the severity of lower respiratory tract infections. Dr. Horvat notes that this study has implications only for influenza A infections and additional research must be done on in
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
22-May-2002


Page: 1 2

Related biology news :

1. Experts Say That Future Inhaled Anti-Viral Drug, Zanamivir Is Effective For Treatment And Prevention Of Influenza
2. Anti-Microbial Agent Kills Influenza Virus
3. Scientists Discover How Influenza Virus Becomes More Deadly
4. Virologists Track New Influenza Threat
5. USC study links historical increases in life span to lower childhood exposure to infection
6. Byproduct of water-disinfection process found to be highly toxic
7. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Promising hospital anti-infection strategy probably wont work, study shows
10. Viral proteins may prevent bacterial infections
11. Researchers develop better understanding of immune response to viral infection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2019)... ... February 26, 2019 , ... ... In her position as Account Manager, Ms. Baptiste demonstrated her ability to advocate ... experience. Ms. Baptiste was responsible for partnering with both the Strategic Development team ...
(Date:2/22/2019)... ... February 21, 2019 , ... Clean label food is ... when creating natural foods and beverages. It is quite common to spot consumers running ... meat products are not immune to this label scrutiny. , More than ever, ...
(Date:2/22/2019)... ... February 21, 2019 , ... The ... executed a research agreement establishing a collaborative program to work toward applications of ... develop new radiopharmaceutical lead candidates and will explore Fuzionaire Dx’s platform as a ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... 14, 2019 , ... Open registration for the Case Management ... of Case Management,” continues as CMSA makes plans to host the annual event ... management industry conference serving the educational and networking needs of case and care ...
(Date:3/14/2019)... (PRWEB) , ... March 13, 2019 , ... ... its 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium ... biotechnology best practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals ...
(Date:3/12/2019)... (PRWEB) , ... March 12, 2019 , ... ... preparation and epigenetics research, has launched its third generation long-fragment DNA shearing innovation, ... generation instrument with a user-friendly interface, automated processing, and the ability to ...
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA Biosciences ... development and commercialization of high performance, cutting-edge cell analysis platforms for life science ... GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to provide ...
Breaking Biology Technology:
Cached News: